Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Witt

Showing results (341-350 of 473) with videos related to

Pageof 48
Sort By:
Nature Communications|October 13, 2025
Capturing disease severity in LIS1-lissencephaly reveals proteostasis dysregulation in patient-derived forebrain organoidsLea Zillich, Matteo Gasparotto, Andrea Carlo Rossetti, et al.
Translational Psychiatry|November 9, 2016
Ankyrin-3 as a molecular marker of early-life stress and vulnerability to psychiatric disordersA Luoni, R Massart, V Nieratschker, et al.
Journal of Medical Genetics|October 4, 2005
Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseasesM Verlaan, J P H Drenth, K Truninger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 31, 2018
Effects of BDNF Val<sup>66</sup>Met genotype and schizophrenia familial risk on a neural functional network for cognitive control in humansJ I Schweiger, E Bilek, A Schäfer, et al.
European Urology Open Science|December 12, 2022
Impact of Surgical Experience Before Robot-assisted Partial Nephrectomy on Surgical Outcomes: A Multicenter Analysis of 2500 PatientsNina N Harke, Markus A Kuczyk, Stephan Huusmann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 25, 2015
NCAN Cross-Disorder Risk Variant Is Associated With Limbic Gray Matter Deficits in Healthy Subjects and Major DepressionUdo Dannlowski, Harald Kugel, Dominik Grotegerd, et al.
JAMA Psychiatry|May 5, 2016
Altered Functional Subnetwork During Emotional Face Processing: A Potential Intermediate Phenotype for SchizophreniaHengyi Cao, Alessandro Bertolino, Henrik Walter, et al.
Translational Psychiatry|January 11, 2017
Functional neuroimaging effects of recently discovered genetic risk loci for schizophrenia and polygenic risk profile in five RDoC subdomainsS Erk, S Mohnke, S Ripke, et al.
Nature Communications|April 9, 2025
Cell type-specific multi-omics analysis of cocaine use disorder in the human caudate nucleusLea Zillich, Annasara Artioli, Veronika Pohořalá, et al.
Schizophrenia Research|April 7, 2009
Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoterJens Treutlein, Thomas W Mühleisen, Josef Frank, et al.
Pageof 48

Showing results (341-350 of 473) with videos related to

Sort By:
Pageof 48
Nature Communications|October 13, 2025
Capturing disease severity in LIS1-lissencephaly reveals proteostasis dysregulation in patient-derived forebrain organoidsLea Zillich, Matteo Gasparotto, Andrea Carlo Rossetti, et al.
Translational Psychiatry|November 9, 2016
Ankyrin-3 as a molecular marker of early-life stress and vulnerability to psychiatric disordersA Luoni, R Massart, V Nieratschker, et al.
Journal of Medical Genetics|October 4, 2005
Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseasesM Verlaan, J P H Drenth, K Truninger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 31, 2018
Effects of BDNF Val<sup>66</sup>Met genotype and schizophrenia familial risk on a neural functional network for cognitive control in humansJ I Schweiger, E Bilek, A Schäfer, et al.
European Urology Open Science|December 12, 2022
Impact of Surgical Experience Before Robot-assisted Partial Nephrectomy on Surgical Outcomes: A Multicenter Analysis of 2500 PatientsNina N Harke, Markus A Kuczyk, Stephan Huusmann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 25, 2015
NCAN Cross-Disorder Risk Variant Is Associated With Limbic Gray Matter Deficits in Healthy Subjects and Major DepressionUdo Dannlowski, Harald Kugel, Dominik Grotegerd, et al.
JAMA Psychiatry|May 5, 2016
Altered Functional Subnetwork During Emotional Face Processing: A Potential Intermediate Phenotype for SchizophreniaHengyi Cao, Alessandro Bertolino, Henrik Walter, et al.
Translational Psychiatry|January 11, 2017
Functional neuroimaging effects of recently discovered genetic risk loci for schizophrenia and polygenic risk profile in five RDoC subdomainsS Erk, S Mohnke, S Ripke, et al.
Nature Communications|April 9, 2025
Cell type-specific multi-omics analysis of cocaine use disorder in the human caudate nucleusLea Zillich, Annasara Artioli, Veronika Pohořalá, et al.
Schizophrenia Research|April 7, 2009
Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoterJens Treutlein, Thomas W Mühleisen, Josef Frank, et al.
Pageof 48